Free Trial

Actinium Pharmaceuticals (ATNM) SEC Filings & 10K Form

Actinium Pharmaceuticals logo
$1.66 -0.05 (-3.16%)
As of 12:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Actinium Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/09/2025
4:27 PM
Actinium Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/02/2025
5:20 PM
Actinium Pharmaceuticals (Issuer)
O'Loughlin Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
5:20 PM
Actinium Pharmaceuticals (Issuer)
SETH SANDESH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
5:21 PM
Actinium Pharmaceuticals (Issuer)
Shetty Ajit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
5:21 PM
Actinium Pharmaceuticals (Issuer)
Nicholson, C. David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
5:22 PM
Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
5:22 PM
Actinium Pharmaceuticals (Issuer)
Chell Jeffrey W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
5:22 PM
Actinium Pharmaceuticals (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:30 PM
Actinium Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:57 PM
Actinium Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
12:33 PM
Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
5:51 PM
Actinium Pharmaceuticals (Subject)
Bigger Capital, LLC (Filed by)
Form SC 13G/A
11/06/2024
6:30 AM
Actinium Pharmaceuticals (Filer)
Form ARS
11/05/2024
4:00 PM
Actinium Pharmaceuticals (Filer)
Form DEF 14A
11/05/2024
4:05 PM
Actinium Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:10 PM
Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/05/2024
4:12 PM
Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:47 AM
Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
11/04/2024
10:10 AM
Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/05/2024
6:30 AM
Actinium Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ATNM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners